Placebo to MK-7240 (tulisokibart)

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Crohn’s Disease or Ulcerative ColitisRheumatoid Arthritis

Phase 2

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Rheumatoid Arthritis

RecruitingCTIS2025-521745-25-00

Merck Sharp & Dohme LLCRheumatoid Arthritis

Start: 2025-11-06Target: 58Updated: 2025-10-31

Phase 3

A Phase 3 Extension Study to Evaluate the Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn’s Disease or Ulcerative Colitis

RecruitingCTIS2024-513533-20-00

Merck Sharp & Dohme LLCCrohn’s Disease or Ulcerative Colitis

Start: 2025-02-25Target: 137Updated: 2025-10-09